Sanofi remporte cette année la palme du champion climatique du CAC40, selon une analyse réalisée par Les Ateliers du futur.
Achieved additional $75 million in partnering proceeds from Sanofi and GileadGranted license to additional preclinical ...
Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, including a ...
6h
Immuneering Reports Third Quarter 2025 Financial Results and Provides Business and Clinical Updates
Announced extraordinary 86% overall survival at 9 months in first-line pancreatic cancer patients treated with atebimetinib + mGnP - - Raised $225 million of financing, including $25 million private ...
Sanofi Consumer Healthcare India Limited ( ($IN:SANOFICONR) ) just unveiled an update. Sanofi Consumer Healthcare India Limited announced the ...
Generative AI models aren’t perfect. Despite constant improvement, they still hallucinate and make mistakes. And for a ...
Global drug stocks rally as the FDA names Richard Pazdur, its top cancer drug regulator, as the head of its influential ...
The antibody-mediated rejection (AMR) market is set for solid expansion through 2034, driven by rising transplant volumes, ...
Q3 2025 Earnings Call November 12, 2025 4:30 PM ESTCompany ParticipantsBenjamin Zeskind - Co-Founder, President, CEO ...
A novel oral therapy that inhibits the interleukin-23 inflammatory pathway provided control of moderate-to-severe psoriasis ...
Most patients with chronic rhinosinusitis with nasal polyps no longer used oral corticosteroids after using dupilumab, according to data presented at the American College of Allergy, Asthma & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback